RAYMOND JAMES & ASSOCIATES - TRINITY BIOTECH PLC ownership

TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 45 filers reported holding TRINITY BIOTECH PLC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of TRINITY BIOTECH PLC
ValueSharesWeighting
Q4 2017$74,000
-59.6%
14,528
-55.4%
0.00%
Q3 2017$183,000
+22.0%
32,560
+29.9%
0.00%
Q2 2017$150,000
-6.2%
25,057
-6.7%
0.00%
Q1 2017$160,000
-17.1%
26,850
-3.8%
0.00%
Q4 2016$193,000
-50.8%
27,904
-6.0%
0.00%
-100.0%
Q3 2016$392,000
+16.0%
29,672
-0.5%
0.00%0.0%
Q2 2016$338,000
+2.4%
29,823
+5.3%
0.00%0.0%
Q1 2016$330,000
+1.5%
28,334
+2.5%
0.00%0.0%
Q4 2015$325,000
+5.9%
27,655
+3.0%
0.00%0.0%
Q3 2015$307,000
-36.7%
26,854
+0.0%
0.00%
-50.0%
Q2 2015$485,000
-6.9%
26,852
-0.8%
0.00%0.0%
Q1 2015$521,000
+9.0%
27,069
-0.8%
0.00%0.0%
Q4 2014$478,000
-10.0%
27,285
-6.1%
0.00%
-33.3%
Q3 2014$531,000
-34.6%
29,050
-17.7%
0.00%
-40.0%
Q2 2014$812,000
+24.9%
35,279
+31.4%
0.01%
+25.0%
Q1 2014$650,000
-38.6%
26,841
-36.3%
0.00%
-50.0%
Q4 2013$1,059,000
+19.9%
42,107
+3.7%
0.01%0.0%
Q3 2013$883,000
+90.7%
40,595
+47.6%
0.01%
+100.0%
Q2 2013$463,00027,5060.00%
Other shareholders
TRINITY BIOTECH PLC shareholders Q1 2018
NameSharesValueWeighting ↓
ACK Asset Management 657,100$11,072,0004.49%
GOLDMAN CAPITAL MANAGEMENT INC 343,000$5,780,0003.30%
Lyon Street Capital, LLC 368,858$6,215,257,0003.08%
JAY JEFFREY R 163,140$2,749,0002.17%
Adirondack Research & Management Inc. 161,507$2,721,0002.03%
Park West Asset Management LLC 448,415$7,556,0000.89%
Benchmark Capital Advisors 51,600$869,0000.67%
SHEPHERD KAPLAN KROCHUK, LLC 166,034$2,797,0000.55%
HEARTLAND ADVISORS INC 1,569,699$26,449,0000.49%
WOODMONT INVESTMENT COUNSEL LLC 86,682$1,461,0000.49%
View complete list of TRINITY BIOTECH PLC shareholders